Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01774851
Title A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

MM-111 + Paclitaxel + Trastuzumab

Paclitaxel + Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.